Written answers
Tuesday, 24 January 2023
Department of Health
Medicinal Products
Róisín Shortall (Dublin North West, Social Democrats)
Link to this: Individually | In context | Oireachtas source
612. To ask the Minister for Health if he will provide an update on the availability of sunosi, which is used to treat narcolepsy and obstructive sleep apnoea in Ireland; and if he will make a statement on the matter. [3238/23]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The Marketing Authorisation Holder for Sunosi, TMC Pharma (EU) Limited, has not placed the product on the Irish market since being granted a marketing authorisation in 2020.
The HSE has confirmed that Sunosi (solriamfetol) was approved for reimbursement under High Tech Arrangements subject to managed access. However, the company have not been in a position to launch the product to date.
No comments